Allurion weight loss balloon | Patient Information

Choose your country or region in order to display more relevant content.

Select

Other country or region

Country

Språk

Continue

Patientinformation

Oavsett om du ska sätta in din ballong snart eller om du är mitt i ditt 16-veckorsprogram finns vi här för att hjälpa dig genom din resa.

Ta reda på vad du kan förvänta dig vid varje steg av din bantningsresa

Få svar från våra viktminskningsexperter

Få tillgång till din data och din statistik från din online portal

Så här ställer du in din anslutna Allurion våg och hälsotracker.

Öppna Allurion App

Logga in på patientsidan idag för att följa dina framsteg

Åtkomst här

Teknisk support för Allurions enheter

Ladda ner våra gratis resurser för din kroppsammansättningsvåg, hälsotracker och mobilapp.

Ladda ned

*As with any medical solution, results may vary from one patient to another, and some patients may not respond to treatment. Please consult a doctor to carefully evaluate the risks and benefits before making your decision.
**Some patients may experience earlier deflation of the Allurion Balloon. The removal of the Allurion Balloon may, in very rare cases, require an endoscopic or surgical intervention. In rare cases, instead of being expelled through the digestive tract, the empty balloon may be vomited out.
***Eligibility for the placement of an Allurion Balloon will be assessed by a certified doctor after an initial consultation and a careful review of your medical history. In the case of an extended Allurion Program, your eligibility is reassessed before each placement to ensure you continue to meet the required conditions.

R. Ienca et al. The procedureless ellipse gastric balloon program: Multicenter experience in 1770 consecutive patients. Obes surg. 2020;30(9):3354-3362. Multicenter, prospective, non-randomized, open registry study conducted in patients with overweight or obesity from January 2016 to June 2019 in 19 international obesity centers participating in the study. A total of 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m2 at baseline underwent treatment with the Elipse swallowable gastric balloon, with a monthly visit and a total follow-up of 4 months. 63 patients (3.6%) did not complete the program, and the balloon was removed before 4 months due to intolerance or other adverse effects.
World Health Organization – Key facts on Obesity and overweight (who.int).
European survey finds over three-quarters of adults with obesity have attempted to lose weight in the past year, but most have been unsuccessful – EASO.
This information is extracted from the instructions for use of the Allurion Gastric Balloon System. Version number CS137-02-ENG. If you have any questions regarding this document, please consult your doctor.

Chat with Ally